Communications and Marketing
Head of Communications and Marketing
Ulrike Grönefeld
Im Neuenheimer Feld 28069120 Heidelberg
Phone: +49 6221 422854
E-Mail: u.groenefeld@dkfz.de
Press Officer
Dr. Sibylle Kohlstädt
Im Neuenheimer Feld 28069120 Heidelberg
Phone: +49 6221 422843
E-Mail: s.kohlstaedt@dkfz.de
Recent Press Releases
The evolution of brain tumors
The evolution of a glioblastoma schematically illustrated
© DKFZ
Scientists from the German Cancer Research Center found in a recent study that only three different genetic alterations drive the early development of malignant glioblastomas. At least one of these three cancer drivers was present in all tumors investigated. However, it is the activation of telomerase that leads to rapid growth. The tumors develop for up to seven years before they become noticeable as symptoms and are diagnosed. However, in contrast to their early development, glioblastomas, which return after therapy, share virtually no concurrent genetic alterations.
From mirror-image biology to enhanced therapeutic proteins
Hands - a prime example of mirror-image biology
© Adobe Stock
Scientists from the German Cancer Research Center (DKFZ) have succeeded in reconstructing biomolecules in their mirror-image form. The researchers' goal is to create a mirror-image artificial protein synthesis system. Their aim is to produce mirror-image therapeutic proteins, such as antibodies, which would be protected from biological breakdown in the body and do not provoke any immune response.
Protein content as a marker for response to therapy in brain cancer
On the left the conventional morphological contrast enhanced imaging of a b...
© D. Paech/DKFZ
Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists from the German Cancer Research Center (DKFZ) have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival.
